A Four-year, Safety and Tolerability, Open-Label, "Follow on" Trial Evaluating Technosphere® Insulin in Subjects With Type 2 Diabetes Mellitus.
Phase of Trial: Phase II
Latest Information Update: 19 Nov 2014
At a glance
- Drugs Insulin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors MannKind Corporation
- 07 Jun 2017 Biomarkers information updated
- 10 May 2011 New source identified and integrated (European Clinical Trials Database, EudraCT2004-001179-21).
- 06 Oct 2009 New trial record.